Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SSY GroupLJUIF 86 OCF Margin % is 23.35% as of Dec. 2025, which is 65% above its 10-year median of 14.13. GuruFocus rates LJUIF with a GF Score™ of 86/100 and a GF Value™ of $0.51. The stock has 8 warning signs investors should review. Among 964 Drug Manufacturers companies, SSY Group ranks better than 65.98% on this metric.
The historical rank and industry rank for SSY Group's OCF Margin % or its related term are showing as below:
LJUIF'
s OCF Margin % Range Over the Past 10 Years
Min: 8.51 Med: 14.13 Max: 29.07
Current: 15.28
During the past 13 years, the highest OCF Margin % of SSY Group was 29.07%. The lowest was 8.51%. And the median was 14.13%.
LJUIF's OCF Margin % is ranked better than 65.98% of 964
companies
in the Drug Manufacturers industry
Industry Median: 10.035
vs LJUIF: 15.28
SSY Group OCF Margin % Related Terms
SSY Group OCF Margin % Historical Data
* Premium members only.
The historical data trend for SSY Group's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SSY Group OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SSY Group's OCF Margin % distribution charts can be found below:
* The bar in red indicates where SSY Group's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SSY Group (LJUIF) has a OCF Margin % of 23.35% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on SSY Group and its competitors. This is 65% above median its historical median of 14.13. Over the past decade, SSY Group's OCF Margin % has ranged from 8.51 to 29.07. According to the industry distribution chart, SSY Group ranks #328 out of 964 companies in the Drug Manufacturers industry, placing it in the top 34%.
Is SSY Group's OCF Margin % too high?
SSY Group's current OCF Margin % of 23.35% is 65% above median its 10-year median of 14.13. Over the past 10 years, this metric has ranged from a low of 8.51 to a high of 29.07. The Drug Manufacturers industry median OCF Margin % is 10.04. SSY Group's value of 23.35% is 132.7% above this industry median. Based on the distribution chart, SSY Group ranks #328 out of 964 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, SSY Group has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does SSY Group's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, SSY Group ranks #328 out of 964 companies for OCF Margin %. This puts SSY Group in the upper half of its industry. The industry median OCF Margin % is 10.04. SSY Group's value of 23.35% is 132.7% above this benchmark. Historically, SSY Group's own OCF Margin % has ranged from 8.51 to 29.07 over the past decade. While the company's 10-year median is 14.13 vs. the industry median of 10.04, SSY Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SSY Group's current OCF Margin % of 23.35% is 132.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on SSY Group and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SSY Group's current OCF Margin % is 23.35%, which is 65% above median its own 10-year median of 14.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SSY Group stock overvalued right now?
SSY Group (LJUIF) has a current OCF Margin % of 23.35%. The stock's GF Value™ is $0.51, compared to a current price of $0.40 — trading 21.1% below its estimated fair value. The current OCF Margin % is 23.35%, which is 65% above median its 10-year median of 14.13 and 132.7% above the Drug Manufacturers industry median of 10.04. SSY Group's overall GF Score™ is 86/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For SSY Group (LJUIF), the current OCF Margin % is 23.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SSY Group (LJUIF) Overvalued in 2026?
Based on GuruFocus' analysis, SSY Group stock appears to be undervalued.
The current stock price of $0.40 is trading 21.1% below its estimated GF Value™ of $0.51.
Key valuation signals for LJUIF:
OCF Margin %: 23.35% (65% above median its 10-year median of 14.13)
GF Value™: $0.51 vs. price of $0.40 (21.1% below fair value)
Industry Position: 132.7% above the Drug Manufacturers median (#328 of 964)
No single metric tells the full story. See the LJUIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSY Group Ltd is engaged in the research, development, manufacturing, and selling of a wide range of pharmaceutical products, which include finished medicines of mainly intravenous infusion solutions and ampoule injections to hospitals and distributors, bulk pharmaceuticals, and medical materials. The company has two reportable segments, including intravenous infusion solutions and other medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products. The company derives maximum revenue from PRC.
86GF Score
Get the complete analysis for LJUIF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LJUIF has been successfully added to your 
